Letosteine: Difference between revisions
m Protected "Letosteine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
Rabin Bista (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
{{ | {{Drugbox | ||
| IUPAC_name | | Verifiedfields = changed | ||
| image | | verifiedrevid = 447814883 | ||
| IUPAC_name = 2-{2-[(2-ethoxy-2-oxoethyl)thio]ethyl}-1,3-thiazolidine-4-carboxylic acid | |||
| | | image = Letostein wiki str.png | ||
<!--Clinical data--> | |||
| tradename = | |||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | |||
| pregnancy_US = <!-- A / B / C / D / X --> | |||
| pregnancy_category = | |||
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> | |||
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> | |||
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> | |||
| pregnancy_AU | | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> | ||
| pregnancy_US | | legal_status = | ||
| pregnancy_category= | | routes_of_administration = | ||
| legal_AU | |||
| legal_CA | <!--Pharmacokinetic data--> | ||
| legal_UK | | bioavailability = | ||
| legal_US | | protein_bound = | ||
| legal_status | | metabolism = | ||
| routes_of_administration = | | elimination_half-life = | ||
| excretion = | |||
<!--Identifiers--> | |||
| CAS_number_Ref = {{cascite|correct|??}} | |||
| CAS_number = 53943-88-7 | |||
| ATC_prefix = R05 | |||
| ATC_suffix = CB09 | |||
| PubChem = 68707 | |||
| DrugBank_Ref = {{drugbankcite|changed|drugbank}} | |||
| DrugBank = DB08939 | |||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | |||
| ChemSpiderID = 61958 | |||
| UNII_Ref = {{fdacite|correct|FDA}} | |||
| UNII = 6MVF9U95DW | |||
| KEGG_Ref = {{keggcite|correct|kegg}} | |||
| KEGG = D07380 | |||
<!--Chemical data--> | |||
| C=10 | H=17 | N=1 | O=4 | S=2 | |||
| molecular_weight = 279.378 g/mol | |||
| smiles = O=C(O)C1NC(SC1)CCSCC(=O)OCC | |||
| InChI = 1/C10H17NO4S2/c1-2-15-9(12)6-16-4-3-8-11-7(5-17-8)10(13)14/h7-8,11H,2-6H2,1H3,(H,13,14) | |||
| InChIKey = IKOCLISPVJZJEA-UHFFFAOYAF | |||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChI = 1S/C10H17NO4S2/c1-2-15-9(12)6-16-4-3-8-11-7(5-17-8)10(13)14/h7-8,11H,2-6H2,1H3,(H,13,14) | |||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChIKey = IKOCLISPVJZJEA-UHFFFAOYSA-N | |||
| synonyms = 2-[2-(ethoxycarbonylmethylsulfanyl)ethyl]-1,3-thiazolidine-4-carboxylic acid | |||
}} | }} | ||
{{ | __NOTOC__ | ||
{{SI}} | |||
{{CMG}} | |||
== Overview == | |||
'''Letosteine''' is a [[mucolytic]] [[patent]]ed ([[U.S.]] patent 6987120) by Piero del Soldato of [[Milan]], [[Italy]].<ref>[http://www.freepatentsonline.com/6987120.html Pharmaceutical compounds.]</ref> He filed his application in 2000. | |||
== References == | |||
{{Reflist|2}} | |||
{{Cough and cold preparations}} | {{Cough and cold preparations}} | ||
[[Category:drug]] | |||
[[Category:Antitussives]] | [[Category:Antitussives]] | ||
[[Category:Carboxylic acids]] | [[Category:Carboxylic acids]] | ||
[[Category:Thioethers]] | [[Category:Thioethers]] | ||
[[Category:Thiazolidines]] | |||
{{ | [[Category:Carboxylate esters]] | ||
[[Category:Ethyl esters]] | |||
{{respiratory-system-drug-stub}} |
Latest revision as of 15:55, 15 April 2015
Clinical data | |
---|---|
Synonyms | 2-[2-(ethoxycarbonylmethylsulfanyl)ethyl]-1,3-thiazolidine-4-carboxylic acid |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C10H17NO4S2 |
Molar mass | 279.378 g/mol |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Letosteine |
Articles |
---|
Most recent articles on Letosteine |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Letosteine at Clinical Trials.gov Clinical Trials on Letosteine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Letosteine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Letosteine Discussion groups on Letosteine Patient Handouts on Letosteine Directions to Hospitals Treating Letosteine Risk calculators and risk factors for Letosteine
|
Healthcare Provider Resources |
Causes & Risk Factors for Letosteine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Letosteine is a mucolytic patented (U.S. patent 6987120) by Piero del Soldato of Milan, Italy.[1] He filed his application in 2000.
References
- Pages with script errors
- Articles with changed DrugBank identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drug
- Antitussives
- Carboxylic acids
- Thioethers
- Thiazolidines
- Carboxylate esters
- Ethyl esters